| 肝动脉和门静脉栓塞化疗联合射频消融治疗原发性肝癌 |
| |
| 引用本文： | 庞志东.肝动脉和门静脉栓塞化疗联合射频消融治疗原发性肝癌[J].实用肝脏病杂志,2008,11(6):391-393. |
| |
| 作者姓名： | 庞志东 |
| |
| 作者单位： | 广西玉林市第一人民医院肝胆外科,537000 |
| |
| 摘 要： | 目的探讨肝动脉栓塞化疗、门静脉栓塞化疗及射频消融治疗不能手术切除的原发性肝癌的临床价值。方法对不能手术切除的56例肝癌患者行肝动脉栓塞化疗联合经皮门静脉栓塞化疗及射频消融综合治疗,并于同期单纯行TACE治疗的病人60例作对照。结果两组病人的肝功能变化差异无显著性意义（均P〉0.05）;两组病人治疗后ATP转阴率差异有显著性意义（P〈0.05）;CR和PR有显著性差异（P〈0.01）;1年及2年生存率差异有显著性意义（P〈0.05）。结论对不能手术切除的肝癌患者行肝动脉栓塞化疗联合经皮门静脉栓塞化疗及射频消融综合治疗能显著提高AFP转阴率、总有效率及生存率,在临床上有较好的应用价值。
|
| 关 键 词： | 肝肿瘤 肝动脉栓塞化疗 门静脉栓塞化疗 射频消融 |
Transcatheter hepatic artery chemoembolization combined with percutaneous portal vein chemoembolization and percutaneous radiofrequency ablation in treatment of patients with unresectable hepatocelular carcinoma |
| |
| PANG Zhidong.Transcatheter hepatic artery chemoembolization combined with percutaneous portal vein chemoembolization and percutaneous radiofrequency ablation in treatment of patients with unresectable hepatocelular carcinoma[J].Journal of Clinical Hepatology,2008,11(6):391-393. |
| |
| Authors: | PANG Zhidong |
| |
| Institution: | PANG Zhidong. (Deportment of General Surgery,The Six Affiliated Hospital,Guangxi Medical University,YuLin,Guang Xi 537000) |
| |
| Abstract: | Objective To explore the clinical value of transcatheter hepatic artery chemoembolization(TACE) combined with percutaneous portal vein chemoembolization(PVCE) and percutaneous radiofrequency ablation(PRFA) in treatment of patients with unresectable hepatocelular carcinoma.Methods 56 patients with unresectable hepatocelular carcinoma were treated with TACE/PVCE/PRFA,and other 60 patients treated with TACE alone for control.Result After the treatment,the hepatic function tests were not significant different b... |
| |
| Keywords: | Hepatoma Transcatheter hepatic artery chemoembolization Percutaneous portal vein chemoembolization Radiofrequency |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
